Deleterious BRCA2 Gene Mutation

specific

A change in the nucleotide sequence of the BRCA2 gene that is associated with increased risk of disease.

48

Centers

7

Active Trials

Cancer Funding

Top Centers for Deleterious BRCA2 Gene Mutation(48)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
70.3
2
NCI Comprehensive
High-Volume Research Center
70.3
3
NCI Comprehensive
High-Volume Research Center
70.3
4
NCI Comprehensive
High-Volume Research Center
70.3
5
High-Volume Research Center
70.3
6
High-Volume Research Center
70.3
7
High-Volume Research Center
70.3
8
NCI Comprehensive
47.8
947.8
10
NCI Comprehensive
47.8
11
NCI Comprehensive
47.8
12
NCI Comprehensive
47.8
1347.8
1447.8
15
NCI Comprehensive
47.8
1647.8
17
NCI Comprehensive
47.8
1847.8
19
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
47.8
20
NCI Comprehensive
47.8
21
NCI Comprehensive
47.8
22
NCI Comprehensive
47.8
23
NCI Comprehensive
47.8
24
NCI Comprehensive
47.8
25
NCI Comprehensive
47.8
26
NCI Comprehensive
47.8
2747.8
28
NCI Comprehensive
47.8
2947.8
30
NCI Comprehensive
47.8
3147.8
3247.8
3347.8
34
NCI Comprehensive
47.8
3547.8
3647.8
3747.8
38
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
47.8
39
NCI Comprehensive
47.8
4047.8
4147.8
4247.8
4347.8
4447.8
4547.8
4647.8
4747.8
4847.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →